News

New research has found a novel target with therapeutic potential for metastatic eye melanoma—an aggressive eye cancer—with ...
Melbourne scientists have shown for the first time how a “revolutionary” blood cancer treatment could be tweaked to also cure ...
CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and ...
“By uncovering specific genetic vulnerabilities like the CDS1 and CDS2 relationship, we’re opening the door to new therapies ...
CRISPR technology is transforming modern medicine by enabling precise DNA editing to treat genetic disorders, including sickle cell anemia and beta-thalassemia, experts say.
Cambridge-driven research has identified a novel target with therapeutic potential for metastatic eye melanoma — an ...
The global Oligonucleotide Synthesis Market is valued at USD 7.78 Billion in 2024 and is projected to reach a value of USD 21 ...
Cancer research no longer moves slowly; it advances rapidly. Revolutionary discoveries in precision medicine, immunotherapy, ...
Another gene-editing tool, CRISPR/Cas9 has been seen as the most sophisticated technology, but Sangamo has advanced faster into clinical trials than the numerous CRISPR innovators.
Intellia Therapeutics NTLA has put up a stellar performance in the past month. Shares of the company have rallied 29.8% ...
Motor City Mile Open Water Swim Makes Waves to Fight Cancer, all proceeds go to University of Michigan cancer center.